These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6172965)
1. Intercalating drugs: DNA binding and molecular pharmacology. Wilson WD; Jones RL Adv Pharmacol Chemother; 1981; 18():177-222. PubMed ID: 6172965 [No Abstract] [Full Text] [Related]
2. The molecular basis for the action of some DNA-binding drugs. Neidle S Prog Med Chem; 1979; 16():151-221. PubMed ID: 95595 [No Abstract] [Full Text] [Related]
3. Identification of the specific sites of interaction between intercalating drugs and DNA. Robbie M; Wilkins RJ Chem Biol Interact; 1984 Apr; 49(1-2):189-207. PubMed ID: 6722935 [TBL] [Abstract][Full Text] [Related]
4. Targeting DNA through-covalent interactions of reversible binding drugs. Graves DE Methods Enzymol; 2001; 340():377-95. PubMed ID: 11494860 [No Abstract] [Full Text] [Related]
10. In vitro antimalarial activity of novel trifluoromethyl- and bis(trifluoromethyl)quinoline derivatives. Kgokong JL; Matsabisa GM; Breytenbach JC Arzneimittelforschung; 2001 Feb; 51(2):163-8. PubMed ID: 11258047 [TBL] [Abstract][Full Text] [Related]
11. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage. Marx G; Zhou H; Graves DE; Osheroff N Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321 [TBL] [Abstract][Full Text] [Related]
12. Aliphatic amine N-oxides of DNA binding agents as bioreductive drugs. Patterson LH; Craven MR; Fisher GR; Teesdale-Spittle P Oncol Res; 1994; 6(10-11):533-8. PubMed ID: 7620222 [TBL] [Abstract][Full Text] [Related]
13. Potential antitumor agents. 53. Synthesis, DNA binding properties, and biological activity of perimidines designed as "minimal" DNA-intercalating agents. Herbert JM; Woodgate PD; Denny WA J Med Chem; 1987 Nov; 30(11):2081-6. PubMed ID: 3669016 [TBL] [Abstract][Full Text] [Related]
14. Alteration of chromatin structure induced by the binding of adriamycin, daunorubicin and ethidium bromide. Grimmond HE; Beerman T Biochem Pharmacol; 1982 Nov; 31(21):3379-86. PubMed ID: 7150361 [TBL] [Abstract][Full Text] [Related]
15. [Affinity between CrIII and purified DNA, studied by competition with an intercalating agent: ethidium bromide]. Vecchio D; Balbi C; Russo P; Parodi S; Santi L Boll Soc Ital Biol Sper; 1981 May; 57(10):1149-55. PubMed ID: 7295400 [TBL] [Abstract][Full Text] [Related]
16. DNA-binding abilities of bisguanylhydrazones of anthracene-9,10-dicarboxaldehyde. Foye WO; Karnik PS; Sengupta SK Anticancer Drug Des; 1986 Apr; 1(2):65-71. PubMed ID: 2453195 [TBL] [Abstract][Full Text] [Related]
17. Volume changes accompanying interaction of ligands with nucleic acids. Marky LA; Kupke DW; Kankia BI Methods Enzymol; 2001; 340():149-65. PubMed ID: 11494847 [No Abstract] [Full Text] [Related]
18. [Formation of free radicals and DNA breaks after pulsed laser irradiation of DNA complexes with intercalating dyes]. Zhizhina GP; Moskalenko SA; Siniak VA; Shekun IuG; Iakshin MA Biofizika; 1990; 35(1):47-52. PubMed ID: 2161260 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic compounds affecting DNA structure and function. Newton BA Adv Pharmacol Chemother; 1970; 8():149-84. PubMed ID: 4109397 [No Abstract] [Full Text] [Related]
20. De-intercalation of ethidium bromide and acridine orange by xanthine derivatives and their modulatory effect on anticancer agents: a study of DNA-directed toxicity enlightened by time correlated single photon counting. Johnson IM; Kumar SG; Malathi R J Biomol Struct Dyn; 2003 Apr; 20(5):677-86. PubMed ID: 12643770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]